Statement of Organization, Functions, and Delegations of Authority, 15984-15985 [2011-6515]
Download as PDF
15984
Federal Register / Vol. 76, No. 55 / Tuesday, March 22, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Combining
Subjective and Objective Methods for
Quantifying Contact Rates and Mixing
Pattern in School-Aged Children,
Funding Opportunity Announcement
(FOA), CK11–006, Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 8 a.m.–5 p.m., May 3, 2011
(Closed).
Place: Sheraton Gateway Hotel Atlanta
Airport, 1900 Sullivan Road, Atlanta, Georgia
30337, Telephone: (770) 997–1100.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Combining Subjective and
Objective Methods for Quantifying Contact
Rates and Mixing Pattern in School-Aged
Children, FOA CK11–006.’’
Contact Person For More Information:
Gregory Anderson, M.S., M.P.H., Scientific
Review Officer, CDC, 1600 Clifton Road, NE.,
Mailstop E60, Atlanta, Georgia 30333,
Telephone: (404) 498–2293. The Director,
Management Analysis and Services Office,
has been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: February 25, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–6641 Filed 3–21–11; 8:45 am]
BILLING CODE 4163–18–P
srobinson on DSKHWCL6B1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
VerDate Mar<15>2010
17:11 Mar 21, 2011
Jkt 223001
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 76 FR 1167, dated
January 7, 2011) is amended to reflect
the reorganization of the Office of
Surveillance, Epidemiology and
Laboratory Services, Centers for Disease
Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows: Delete in its entirety the title for
the Knowledge Management Branch
(CPGBB). within the Division of
Laboratory Policy and Practice (CPGB),
Laboratory Science Policy and Practice
Program Office (CPG), Office of
Surveillance, Epidemiology and
Laboratory Services (CP) and insert the
Technology Management Branch
(CPGBB).
Following the title and functional
statement for the Laboratory Policy
Branch (CPGBC), insert the following:
Laboratory Training Branch (CPGBD).
(1) Provides advanced laboratory
training to maintain a competent,
prepared, and sustainable national/
global laboratory workforce; (2)
analyzes, designs, develops, and
implements effective needs-based
training pertaining to public health
laboratory methodology and technology;
(3) evaluates the efficiency and
effectiveness of public health laboratory
education and training for state and
local public health, clinical, military,
CDC, and other federal agency
laboratorians; and (4) evaluates the
effectiveness and measures the
outcomes of all training to ensure a high
quality product for all end users.
Delete in its entirety the functional
statement for the Division of Leadership
and Practice (CPLC) within the
Scientific Education and Professional
Development Program Office (CPL),
Office of Surveillance, Epidemiology
and Laboratory Services (CP) and insert
the following:
Division of Leadership and Practice
(CPLC). (1) Plans, directs, and manages
CDC-wide training and service programs
for the teaching and training of public
health professionals in public health
practice, including public health
leadership and management, public
policy, program planning,
implementation, and evaluation; (2)
plans, directs, and manages CDC-wide
training and service programs for
fellowships and internships sponsored
by other partner organizations and
implemented within CDC (e.g.,
Emerging Leaders Program, Presidential
Management Fellowship, and
Association of Schools of Public Health
Fellowship); (3) incorporates principles
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
of adult learning theory and current
learning standards into the design,
delivery, and evaluation of education
and training products; (4) leads content
development and implementation of
workforce development programs
intended to increase the number of
individuals choosing public health
careers; (5) responds to domestic and
international requests for assistance and
consultation (Emergency Operations
Center deployment); (6) maintains
knowledge of continuing education
standards to uphold national
accreditations and provides guidance
and consultation, incorporating
principles of adult learning theory with
course developers to ensure educational
activities are accredited for continuing
education; (7) works with partner
agencies to articulate and build
curricula for public health workforce
competencies in leadership and
management; (8) maintains liaison with
other governmental agencies, academic
institutions and organizations, state and
local health agencies, private health
organizations, professional
organizations, and other outside groups;
(9) provides technical assistance,
consultation, resources and training for
SEPDPO, other CDC fellowships, and
the broader health workforce, including,
but not limited to the development and
dissemination of standard curricula,
training, and related materials, in
leadership and management; (10)
develops and maintains appropriate
internal and external partnerships to
foster best practices in the design and
delivery of educational activities and
training; and (11) collaborates, as
appropriate, with the CDC OD, other
CIOs, and domestic and international
agencies to carry out the functions of the
division.
Following the title and functional
statement for the Public Health
Prevention Service Branch (CPLCC),
insert the following:
Educational Design and Accreditation
Branch (CPLCD). (1) Provides
consultation, guidance, and technical
assistance to course developers,
incorporating principles of learning
theory to ensure consistent design and
delivery of accredited educational
activities; (2) maintains knowledge of
continuing education standards and
applies quality assurance practices
required to uphold national
accreditations; (3) assesses need and
demand for additional accreditations to
support professional license and
certification needs of technical and
professional staff within the health
workforce; (4) develops and maintains
internal and external partnerships to
foster best practices in the design and
E:\FR\FM\22MRN1.SGM
22MRN1
Federal Register / Vol. 76, No. 55 / Tuesday, March 22, 2011 / Notices
delivery of educational activities and
training; (5) maintains knowledge of
information technology and learning
standards as they apply to education
and training to demonstrate and
promote compliance and best practices
by CDC programs; (6) applies the
principles of instructional systems
design and learning theory to design,
develop, deliver, and evaluate
informational and instructional
products; (7) implements and maintains
the CDC Training and Continuing
Education Online web-based
accreditation and registration system;
(8) adapts information systems and
processes to reflect current best
practices and adherence to accreditation
requirements; and (9) provides technical
assistance and guidance to learners to
ensure accreditation and learner
support.
Delete in its entirety the title and
functional statement for the Division of
Training Development and Services
(CPLD) within the Scientific Education
and Professional Development Program
Office (CPL), Office of Surveillance,
Epidemiology and Laboratory Services
(CP)
Dated: March 10, 2011.
James D. Seligman,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2011–6515 Filed 3–21–11; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–1991–F–0203] (Formerly
Docket No. 91F–0111)
Hartech Corporation; Denial Without
Prejudice of Food Additive Petition
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is denying a food
additive petition (FAP 1M4246)
proposing that the food additive
regulations be amended to provide for
the safe use of a source of ionizing
radiation to treat shellfish, including
crustaceans.
srobinson on DSKHWCL6B1PROD with NOTICES
SUMMARY:
This order is effective June 20,
2011; except as to any provisions that
may be stayed by the filing of proper
objections. Submit either electronic or
written objections and requests for a
hearing by April 21, 2011.
ADDRESSES: You may submit either
electronic or written objections and
DATES:
VerDate Mar<15>2010
17:11 Mar 21, 2011
Jkt 223001
requests for a hearing identified by
Docket No. FDA–1991–F–0203, by any
of the following methods:
Electronic Submissions
Submit electronic objections in the
following way:
Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Written Submissions
Submit written objections in the
following ways:
Fax: 301–827–6870.
Mail/Hand delivery/Courier (for
paper, disk, or CD–ROM submissions):
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville,
MD 20852.
FOR FURTHER INFORMATION CONTACT:
Richard E. Bonnette, Center for Food
Safety and Applied Nutrition (HFS–
255), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park,
MD 20740–3835, 301–436–1235.
SUPPLEMENTARY INFORMATION: In a notice
published in the Federal Register of
April 16, 1991 (56 FR 15373), FDA
announced that a food additive petition
(FAP 1M4246) had been filed by
Hartech Corp. (formerly United States
Harvest Technologies, Inc., One East
Chase St., suites 1112 and 1113,
Baltimore, MD). The petition proposed
to amend the food additive regulations
in § 179.26 Ionizing radiation for the
treatment of food (21 CFR 179.26) to
provide for the safe use of a source of
ionizing radiation to treat shellfish,
including crustaceans.
For any food additive petition, the
burden is on the petitioner to submit to
FDA data and information that are
adequate for the Agency to determine
that the proposed use of the additive
under the specified conditions of use is
safe (21 U.S.C. 348(c)(3)(A), 21 CFR
171.1). Hartech Corp. was notified of
significant deficiencies in the
information supporting its petition by
letters from the Agency dated May 28,
1992, February 5, 1999, December 15,
2004, March 19, 2009, and May 22,
2009. The deficiencies related primarily
to concerns about the possibility of
Clostridium botulinum outgrowth in
irradiated products, especially where
the normal growth pattern of typical
spoilage organisms could be changed by
irradiation, thus reducing perception of
spoilage. FDA had therefore requested
information on typical spoilage and
pathogenic microbial populations of
shellfish irradiated at the maximum
dose requested. FDA also requested
additional data on the efficacy of the
proposed doses of irradiation in
reducing pathogens in crustaceans
PO 00000
Frm 00052
Fmt 4703
Sfmt 9990
15985
because the petition only included data
on the efficacy of irradiation in reducing
the levels of Vibrio species in oysters.
Hartech Corp. has not provided
information to address these
deficiencies, and the Agency’s most
recent letters to Hartech Corp.’s last
known address were returned as
undeliverable. Additional efforts to
contact this petitioner have been
unsuccessful. The petitioner has not
provided sufficient data and
information for the Agency to conclude
that the proposed use of the food
additive is safe in accordance with
section 409 of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 348). FDA
is therefore denying the petition without
prejudice to a future filing (21 U.S.C.
348(c)(1)(B), 21 CFR 171.100(a)).
This order is effective as shown in the
DATES section of this document; except
as to any provisions that may be stayed
by the filing of proper objections. Any
person who will be adversely affected
by this order may file with the Division
of Dockets Management (see ADDRESSES)
either electronic or written objections.
Each objection shall be separately
numbered, and each numbered
objection shall specify with particularity
the provisions of the regulation to
which objection is made and the
grounds for the objection. Each
numbered objection on which a hearing
is requested shall specifically so state.
Failure to request a hearing for any
particular objection shall constitute a
waiver of the right to a hearing on that
objection. Each numbered objection for
which a hearing is requested shall
include a detailed description and
analysis of the specific factual
information intended to be presented in
support of the objection in the event
that a hearing is held. Failure to include
such a description and analysis for any
particular objection shall constitute a
waiver of the right to a hearing on the
objection. It is only necessary to send
one set of documents. It is no longer
necessary to send three copies of all
documents. Identify documents with the
docket number found in brackets in the
heading of this document. Any
objections received in response to the
order may be seen in the Division of
Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
FDA will publish notice of the
objections that the Agency has received
or lack thereof in the Federal Register.
Dated: March 15, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–6624 Filed 3–21–11; 8:45 am]
BILLING CODE 4160–01–P
E:\FR\FM\22MRN1.SGM
22MRN1
Agencies
[Federal Register Volume 76, Number 55 (Tuesday, March 22, 2011)]
[Notices]
[Pages 15984-15985]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-6515]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 76 FR 1167, dated January 7, 2011) is amended
to reflect the reorganization of the Office of Surveillance,
Epidemiology and Laboratory Services, Centers for Disease Control and
Prevention.
Section C-B, Organization and Functions, is hereby amended as
follows: Delete in its entirety the title for the Knowledge Management
Branch (CPGBB). within the Division of Laboratory Policy and Practice
(CPGB), Laboratory Science Policy and Practice Program Office (CPG),
Office of Surveillance, Epidemiology and Laboratory Services (CP) and
insert the Technology Management Branch (CPGBB).
Following the title and functional statement for the Laboratory
Policy Branch (CPGBC), insert the following:
Laboratory Training Branch (CPGBD). (1) Provides advanced
laboratory training to maintain a competent, prepared, and sustainable
national/global laboratory workforce; (2) analyzes, designs, develops,
and implements effective needs-based training pertaining to public
health laboratory methodology and technology; (3) evaluates the
efficiency and effectiveness of public health laboratory education and
training for state and local public health, clinical, military, CDC,
and other federal agency laboratorians; and (4) evaluates the
effectiveness and measures the outcomes of all training to ensure a
high quality product for all end users.
Delete in its entirety the functional statement for the Division of
Leadership and Practice (CPLC) within the Scientific Education and
Professional Development Program Office (CPL), Office of Surveillance,
Epidemiology and Laboratory Services (CP) and insert the following:
Division of Leadership and Practice (CPLC). (1) Plans, directs, and
manages CDC-wide training and service programs for the teaching and
training of public health professionals in public health practice,
including public health leadership and management, public policy,
program planning, implementation, and evaluation; (2) plans, directs,
and manages CDC-wide training and service programs for fellowships and
internships sponsored by other partner organizations and implemented
within CDC (e.g., Emerging Leaders Program, Presidential Management
Fellowship, and Association of Schools of Public Health Fellowship);
(3) incorporates principles of adult learning theory and current
learning standards into the design, delivery, and evaluation of
education and training products; (4) leads content development and
implementation of workforce development programs intended to increase
the number of individuals choosing public health careers; (5) responds
to domestic and international requests for assistance and consultation
(Emergency Operations Center deployment); (6) maintains knowledge of
continuing education standards to uphold national accreditations and
provides guidance and consultation, incorporating principles of adult
learning theory with course developers to ensure educational activities
are accredited for continuing education; (7) works with partner
agencies to articulate and build curricula for public health workforce
competencies in leadership and management; (8) maintains liaison with
other governmental agencies, academic institutions and organizations,
state and local health agencies, private health organizations,
professional organizations, and other outside groups; (9) provides
technical assistance, consultation, resources and training for SEPDPO,
other CDC fellowships, and the broader health workforce, including, but
not limited to the development and dissemination of standard curricula,
training, and related materials, in leadership and management; (10)
develops and maintains appropriate internal and external partnerships
to foster best practices in the design and delivery of educational
activities and training; and (11) collaborates, as appropriate, with
the CDC OD, other CIOs, and domestic and international agencies to
carry out the functions of the division.
Following the title and functional statement for the Public Health
Prevention Service Branch (CPLCC), insert the following:
Educational Design and Accreditation Branch (CPLCD). (1) Provides
consultation, guidance, and technical assistance to course developers,
incorporating principles of learning theory to ensure consistent design
and delivery of accredited educational activities; (2) maintains
knowledge of continuing education standards and applies quality
assurance practices required to uphold national accreditations; (3)
assesses need and demand for additional accreditations to support
professional license and certification needs of technical and
professional staff within the health workforce; (4) develops and
maintains internal and external partnerships to foster best practices
in the design and
[[Page 15985]]
delivery of educational activities and training; (5) maintains
knowledge of information technology and learning standards as they
apply to education and training to demonstrate and promote compliance
and best practices by CDC programs; (6) applies the principles of
instructional systems design and learning theory to design, develop,
deliver, and evaluate informational and instructional products; (7)
implements and maintains the CDC Training and Continuing Education
Online web-based accreditation and registration system; (8) adapts
information systems and processes to reflect current best practices and
adherence to accreditation requirements; and (9) provides technical
assistance and guidance to learners to ensure accreditation and learner
support.
Delete in its entirety the title and functional statement for the
Division of Training Development and Services (CPLD) within the
Scientific Education and Professional Development Program Office (CPL),
Office of Surveillance, Epidemiology and Laboratory Services (CP)
Dated: March 10, 2011.
James D. Seligman,
Acting Chief Operating Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2011-6515 Filed 3-21-11; 8:45 am]
BILLING CODE 4160-18-M